Genmab A+s

Bart De Goeij

Paul Parren

Jan Van De Winkel

Janine Schuurman

Aran Frank Labrijn

Edward Norbert Van Den Brink

Joost J Neijssen

David Satijn

Ole Baadsgaard

Rik Rademaker

Rene Hoet

Tom Vink

Isil Altintas

Joyce Meesters

Simone De Haij

Patrick Van Berkel

Esther Breij

Dennis Verzijl

Thilo Riedl

Ewald T J Van Den Bremer

Rene M A Hoet

Jan Van Winkel

Ewald Van Den Bremer

Joyce I Meesters

René Hoet

Simone Haij

Joost Melis

Hendrik Ten Napel

Edward N Brink

Rene M Hoet

Ewald Van Bremer

Kristin Strumane

Novel heterodimeric antibody-Fc-containing proteins, such as bispecific antibodies, and novel methods for producing such proteins.

Heterodimeric antibody Fc-containing proteins and methods for production thereof

Bispecific antibodies which comprise one antigen-binding region binding to an epitope of human epidermal growth factor receptor 2 (HER2) and one antigen-binding region binding to human CD3, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods for preparing and using the antibodies are also disclosed.

Bispecific antibodies against HER2 and CD3

Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Monoclonal antibodies against c-Met

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Monoclonal antibodies against HER2

Monoclonal antibodies against HER2 epitope

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related anti-body-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Heterodimeric antibody-Fc-containing proteins, such as bispecific antibodies, and novel methods for producing such proteins.

Growing community of inventors

Maarssen, Netherlands

Bart De Goeij